Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6488-6494

  Muir, Eric R ^a   Rentería, René C ^a   Duong, Timothy Q ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CHOROID BLOOD FLOW; CONTRAST SENSITIVITY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GENOTYPE; HETEROZYGOTE; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR BLOOD FLOW; PERIMETRY; PRIORITY JOURNAL; RETINA BLOOD FLOW; VISION; VISUAL IMPAIRMENT; VISUAL SYSTEM PARAMETERS; ANIMAL; C57BL MOUSE; CHOROID; DISEASE MODEL; EARLY DIAGNOSIS; GENETICS; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PHOTOSTIMULATION; PHYSIOLOGY; RETINA; RETINA BLOOD VESSEL; VASCULARIZATION;

INS2 PROTEIN, MOUSE; INSULIN;

ANIMALS; CHOROID; CONTRAST SENSITIVITY; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; FEMALE; HYPERGLYCEMIA; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHOTIC STIMULATION; REGIONAL BLOOD FLOW; RETINA; RETINAL VESSELS; SENSORY THRESHOLDS;

EID: 84871898419     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9758     Document Type: Article

References (50)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
2. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond). 2002;16:242-260.
3. Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy: early functional changes. Clinical Exp Pharm Physiol. 1997;24:785-788.
4. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol. 1996; 80:327-331.
5. Tregear SJ, Knowles PJ, Ripley LG, Casswell AG. Chromaticcontrast threshold impairment in diabetes. Eye. 1997;11:537-546.
6. Pemp B, Schmetterer L. Ocular blood flow in diabetes and agerelated macular degeneration. Can J Ophthalmol. 2008;43: 295-301.
7. Lorenzi M, Feke GT, Cagliero E, et al. Retinal haemodynamics in individuals with well-controlled type 1 diabetes. Diabetologia. 2008;51:361-364.
8. Pemp B, Polska E, Garhofer G, Bayerle-Eder M, Kautzky-Willer A, Schmetterer L. Retinal blood flow in type 1 diabetes patients with no or mild diabetic retinopathy during euglycemic clamp. Diabetes Care. 2010;33:2038-2042.
9. Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. BMJ. 1992;305:678-683.
10. Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A. Reduced retinal blood flow velocity in diabetic retinopathy. Retina. 2010;30:765-773.
11. Schocket LS, Brucker AJ, Niknam RM, Grunwald JE, DuPont J, Brucker AJ. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol. 2004;25:89-94.
12. Gilmore ED, Hudson C, Nrusimhadevara RK, et al. Retinal arteriolar hemodynamic response to an acute hyperglycemic provocation in early and sight-threatening diabetic retinopathy. Microvasc Res. 2007;73:191-197.
13. Lee S, Harris NR. Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice. Microcircul. 2008;15: 379-387.
14. Wright WS, Harris NR. Ozagrel attenuates early streptozotocininduced constriction of arterioles in the mouse retina. Exp Eye Res. 2008;86:528-536.
15. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell SE. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci. 1994;35:981-990.
16. Lee S, Morgan GA, Harris NR. Ozagrel reverses streptozotocininduced constriction of arterioles in rat retina. Microvasc Res. 2008;76:217-223.
17. Braun RD, Wienczewski CA, Abbas A. Erythrocyte flow in choriocapillaris of normal and diabetic rats. Microvasc Res. 2009;77:247-255.
18. Tadayoni R, Paques M, Gaudric A, Vicaut E. Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice. Exp Eye Res. 2003;77:497-504.
19. Tilton RG, Chang K, Pugliese G, et al. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes. 1989; 38:1258-1270.
20. Cringle SJ, Yu DY, Adler VA, Su EN. Retinal blood flow by hydrogen clearance polarography in the streptozotocininduced diabetic rat. Invest Ophthalmol Vis Sci. 1993;34: 1716-1721.
21. Della Sala S, Bertoni G, Somazzi L, Stubbe F, Wilkins AJ. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985;69:136-142.
22. Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55:2401-2411.
23. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.
24. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2Akita diabetic mice. Invest Ophthalmol Vis Sci. 2008;49:2635-2642.
25. Chen Y, Hu Y, Zhou T, et al. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol. 2009;175:2676-2685.
26. Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest. 1999;103:27-37.
27. Muir ER, Duong TQ. MRI of retinal and choroidal blood flow with laminar resolution. NMR Biomed. 2011;24:216-223.
28. Akimov NP, Rentería RC. Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2(Akita) mouse model of diabetes. Behav Brain Res. 2012;226:601-605.
29. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004;45:4611-4616.
30. Douglas RM, Alam NM, Silver BD, McGill TJ, Tschetter WW, Prusky GT. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Visual Neurosci. 2005;22:677-684.
31. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stressmediated diabetes. J Clin Invest. 2002;109:525-532.
32. Muir ER, Shen Q, Duong TQ. Cerebral blood flow MRI in mice using the cardiac spin-labeling technique. Magn Reson Med. 2008;60:744-748.
33. Shen Q, Ren H, Cheng H, Fisher M, Duong TQ. Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow and Metab. 2005;25:1265-1279.
34. Herscovitch P, Raichle ME. What is the correct value for the brain-blood partition coefficient for water? J Cereb Blood Flow Metab. 1985;5:65-69.
35. Nair G, Shen Q, Duong TQ. Relaxation time constants and apparent diffusion coefficients of rat retina at 7 Tesla. Int J Imaging Syst Technol. 2010;20:126-130.
36. Cheng H, Nair G, Walker TA, et al. Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci U S A. 2006;103:17525-17530.
37. Muir ER, Duong TQ. Layer-specific functional and anatomical MRI of the retina with passband balanced SSFP. Magn Reson Med. 2011;66:1416-1421.
38. McLeod DS, Lutty GA. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci. 1994;35:3799-3811.
39. Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45: 2760-2766.
40. Kohzaki K, Vingrys AJ, Bui BV. Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2008;49:3595-3604.
41. Johnson MA, Lutty GA, McLeod DS, et al. Ocular structure and function in an aged monkey with spontaneous diabetes mellitus. Exp Eye Res. 2005;80:37-42.
42. Clermont AC, Bursell SE. Retinal blood flow in diabetes. Microcirculation. 2007;14:49-61.
43. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37:886-897.
44. Park H-J, Zhang Y, Du C, et al. Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type I diabetic Akita mice. Circ Res. 2009;105:287-294.
45. Basu R, Oudit GY, Wang X, et al. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol. 2009;297:H2096-H2108.
46. Sicard K, Shen Q, Brevard ME, et al. Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab. 2003;23: 472-481.
47. Brian JE, Bogan L, Kennedy RH, Seifen E. The impact of streptozotocin-induced diabetes on the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetics in the rat. Anesth Analg. 1993;77:342-345.
48. Li Y, Cheng H, Shen Q, et al. Blood-flow magnetic resonance imaging of retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:1824-1830.
49. Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 1999;44:53-60.
50. Krause MP, Riddell MC, Gordon CS, Imam SA, Cafarelli E, Hawke TJ. Diabetic myopathy differs between Ins2Akita+/-and streptozotocin-induced type 1 diabetic models. J Appl Physiol. 2009;106:1650-1659.